AI News and Headlines

AI Boosts Drug Discovery and Commercialization Efficiency

A new study by researchers Pipada, Bikkina, and Joshi demonstrates that artificial intelligence can dramatically streamline pharmaceutical drug discovery and commercialization. The analysis shows AI‑driven platforms can halve development timelines and cut R&D expenditures by roughly a third while boosting predictive accuracy for clinical success. By automating target identification, molecular design, and market forecasting, AI enables faster progression from lab to market. The findings suggest a paradigm shift toward data‑centric pipelines across the industry.